Prehospital Analgesia INtervention Trial (PAIN)
Start Date
11/27/2023
Completion Date
7/1/2029
Summary
The Prehospital Analgesia INtervention trial (PAIN) is a proposed 4 year (3-year enrollment) multicenter, prehospital, randomized, double-blind, clinical trial that will enroll approximately 994 patients at select LITES Network sites. The objective is to perform a prospective, interventional, randomized trial among prehospital trauma patients with compensated shock (SI≥0.9 or HR ≥115) and an indication for pain management, comparing patient centered outcomes following prehospital administration of ketamine hydrochloride versus fentanyl citrate.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Ketamine Hydrochloride
Fentanyl Citrate
Conditions
Locations
University of California, San Diego
San Diego, California 92103
United States
Zuckerberg San Francisco General Hospital
San Francisco, California 94110
United States
Cooper University Health Care
Camden, New Jersey 08103
United States
Atrium Health and Carolinas Medical Center
Charlotte, North Carolina 28203
United States
University of Cincinnati
Cincinnati, Ohio 45267
United States
Allegheny Health Network (AHN) Allegheny General Hospital
Pittsburgh, Pennsylvania 15212
United States
University of Pittsburgh
Pittsburgh, Pennsylvania 15213
United States
Guthrie Robert Packer Hospital
Sayre, Pennsylvania 18840
United States
University of Utah
Salt Lake City, Utah 84132
United States
The University of Vermont Larner College of Medicine
Burlington, Vermont 05405
United States
Medical College of Wisconsin
Milwaukee, Wisconsin 53266
United States